QQ客服 官方微博 反馈留言

	miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
	Zhang, Guangwei[1]; Tian, Xin[2]; Li, Yang[3]; Wang, Zhiqiang[4]; Li, Xiaodong[5]; Zhu, Chaoyang[6]
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2018
卷号	97页码:736-744
关键词	MiR-27b miR-34a Docetaxel sensitivity ZEB1 EMT Prostate cancer
ISSN号	0753-3322
DOI	http://dx.doi.org/10.1016/j.biopha.2017.10.163
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000419041300088
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5180505
专题	河南大学
作者单位	1.[1]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 2.[2]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 3.[3]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 4.[4]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 5.[5]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 6.[6]Henan Univ, Huaihe Hosp, Dept Urol, 8 Baobei Rd, Kaifeng 475000, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Guangwei[1],Tian, Xin[2],Li, Yang[3],et al. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,97:736-744.
APA	Zhang, Guangwei[1],Tian, Xin[2],Li, Yang[3],Wang, Zhiqiang[4],Li, Xiaodong[5],&Zhu, Chaoyang[6].(2018).miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.BIOMEDICINE & PHARMACOTHERAPY,97,736-744.
MLA	Zhang, Guangwei[1],et al."miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1".BIOMEDICINE & PHARMACOTHERAPY 97(2018):736-744.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。